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Abstract
Background: The management of hepatic hemangiomas remains ill defined. This study sought to
investigate the indications, surgical management and outcomes of patients who underwent a resection
for hepatic hemangiomas.
Methods: A retrospective review from six major liver centres in the United States identifying patients
who underwent surgery for hepatic hemangiomas was performed. Clinico-pathological, treatment and
peri-operative data were evaluated.
Results: Of the 241patients who underwent a resection, the median age was 46 years [interquartile
range (IQR): 39–53] and 85.5% were female. The median hemangioma size was 8.5 cm (IQR: 6–12.1).
Surgery was performed for abdominal symptoms (85%), increasing hemangioma size (11.3%) and patient
anxiety (3.7%). Life-threatening complications necessitating a hemangioma resection occurred in three
patients (1.2%). Clavien Grade 3 or higher complications occurred in 14 patients (5.7%). The 30- and
90-day mortality was 0.8% (n = 2). Of patients with abdominal symptoms, 63.2% reported improvement
of symptoms post-operatively.
Conclusion: A hemangioma resection can be safely performed at high-volume institutions. The primary
indication for surgery remains for intractable symptoms. The development of severe complications
associated with non-operative management remains a rare event, ultimately challenging the necessity of
additional surgical indications for a hemangioma resection.
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Introduction
The increasing use of abdominal imaging modalities has resulted
in a greater frequency of benign liver tumours being identified
annually. Hepatic hemangiomas are the most common neoplasm
of the liver, with an estimated prevalence of 3% to 20%.1 The
development of hemangiomas remains poorly understood;
however, studies have suggested oestrogen exposure as a poten-
tial pathophysiological mechanism.2,3 Enlargement of these
lesions follows an ectatic growth pattern rather than through
neoplasia. Grossly, hemangiomas are well-circumscribed and
compressible lesions. Histologically, multiple blood vessels lined
by endothelial cells are present.4 In spite of the absent risk of
malignant transformation and otherwise benign clinical course,
a uniform management approach for hepatic hemangiomas is
lacking.
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The majority of hemangiomas are small asymptomatic lesions
that are managed non-operatively. Multiple series have demon-
strated that asymptomatic hemangiomas can be safely observed as
a result of the low complication rates.5–7 However, these tumours
have the ability to grow, potentially creating abdominal symp-
toms, most commonly manifested as pain. In the setting of
abdominal symptoms, there is little controversy that a resection is
warranted.Aside for symptoms, there has been a lack of consensus
regarding additional indications to perform surgery for this
benign tumour. Contemporary series have proposed extending
the surgical criteria for lesions that present a diagnostic dilemma,
patient anxiety, giant hemangiomas, or hemangiomas that dem-
onstrate progressive enlargement.5,8 However, the majority of the
studies evaluating surgical resection for hepatic hemangiomas are
from small, single institution series. This creates difficulties when
attempting to extrapolate the results to the general population and
has led to a lack of uniform adoption of surgical indications. In
the present multi-institutional study, a large series of resected
hemangiomas is presented in an attempt to better understand the
indications, safety and outcomes associated with hepatic
hemangioma surgery.
Patients and methods
Patient selection
Approval was obtained from the Institutional Review Boards of
each contributing institution (University of Wisconsin, Madison,
WI; Ohio State University, Columbus, OH; University of
Pittsburg, Pittsburg, PA; Emory University, Atlanta, GA; Johns
Hopkins University, Baltimore, MD; and Medical College of Wis-
consin, Milwaukee, WI). Using a multi-institutional database,
patients with resected liver hemangiomas from 1994–2013 were
identified. Inclusion criteria required that a resection of the
hemangioma was the primary indication for surgery. Incidental
findings of a hemangioma after pathological analysis of the
resected specimen were excluded. All patients included in the
analysis underwent a pre-operative computed tomography or
magnetic resonance imaging prior to resection.
Data collection
Standard demographic and clinicopathological data were col-
lected for each patient. Primary tumour characteristics assessed
were size, location and number of lesions. Data on pre-operative
variables were obtained, such as albumin, total bilirubin and inter-
national normalized ratio levels. Peri-operative details included
indications for surgery, type of surgical therapy, operative blood
loss and intra-operative blood transfusions. Morbidity was
assessed according to the Clavien–Dindo classification system.9
Grade III or higher complications were included in the study.
Peri-operative mortality was assessed at two different time points;
30 and 90 days after their index surgery. Symptom resolution
within 90 days post procedure was evaluated by abstraction of
clinical records.
Statistical analysis
Discrete variables were reported as totals and frequencies, whereas
continuous data were described as median values ± interquartile
range (IQR). Factors associated with symptom development were
assessed with logistic regression. Statistical significance was set at
α = 0.05. Statistical analyses were performed with Stata/MP 10.0
for Windows (StataCorp, College Station, TX, USA).
Results
There were 241 patients who underwent a hemangioma resection
at six major hepatobiliary centres. Clinicopathological and
tumour characteristics of the study cohort are shown in Table 1.
The median age of the collective cohort was 46 (IQR: 39–53), with
the majority of patients being female (n = 206, 85.8%). The
primary clinical presentation that lead to hemangioma diagnosis
was abdominal pain (n = 215, 89.2%). Traumatic hemangioma
rupture necessitating operative management occurred in only
three patients (1.2%).
Operative details and outcomes are shown in Tables 2 and 3.
The primary surgical indication for resection of a hemangioma
was attributed to abdominal symptoms (n = 204, 85%).
A total of 14 patients (5.7%) experienced a Clavien Grade III or
greater complication during their post-operative course. There
were two postoperative deaths (0.8%) that occurred within 30
days with no additional mortalities at 90 days.
For the subgroup of patients who underwent surgery owing to
abdominal symptoms, 63.2% (n = 129) of patients were identified
as having symptom resolution within 90 days after the index
operation. Univariate logistic regression was unable to identify
factors associated with the development of abdominal symptoms
(Table 4).
Discussion
Operative intervention for liver hemangiomas remains a contro-
versial topic. Previous studies from major hepatobiliary centres
have proposed varying indications for a hemangioma resection.
Findings from the present study demonstrate that operative man-
agement of symptomatic hemangiomas remains an effective
therapy and can be performed with low morbidity to the patient.
However, aside from abdominal symptoms, prophylactic resec-
tions in the setting of hemangioma enlargement, size, or patient
anxiety is not advised as the risk of developing life-threatening
associated complications is rare.
At present, resection of symptomatic hepatic hemangiomas
remains a widely accepted indication for surgical management.
This study and others have demonstrated that the majority of
patients will experience resolution of their pre-operative symp-
toms after surgery. Across published series, 70% to 100% of symp-
tomatic patients derived a benefit from surgical therapy.6,8,10,11 In
the current series, of the 204 patients that underwent surgery for
abdominal symptoms, 129 (63.2%) patients within 90 days
reported improvement in symptoms post-operatively. Moreover,
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as demonstrated by Schnelldorfer, attempts at non-operative
management for symptomatic hemangiomas often does not result
in symptom resolution.7 In their series, of the 46 symptomatic
patients treated by clinical observation, symptoms persisted or
escalated in 61% of the cohort. In comparison, all of the sympto-
matic patients treated surgically in the study reported resolution
of their pre-operative symptoms. Clearly, surgery has an estab-
lished role in the treatment algorithm for hepatic hemangiomas in
symptomatic patients.
Beyond patients with intractable abdominal symptoms, addi-
tional surgical criteria warranting a hemangioma resection
remains poorly defined.Although an extremely rare event as dem-
onstrated by only one patient (0.3%) possessing this disorder, the
presence of Kasabach–Merritt Syndrome in the setting of
hemangioma development may also be a tenable indication for
operative intervention. However, identifying additional criteria to
support operative management of hemangiomas remains a con-
tentious topic as several modern series have demonstrated that
observation of completely asymptomatic hemangiomas, regard-
less of size is safe.6,7,12 In the study by Schnelldorfer, only 9% of
patients developed new onset hemangioma-associated symptoms
among the non-operative cohort.7 The majority of symptoms
Table 1 Patient demographics and hemangioma characteristics in
patients that underwent a liver resection
Variable All patients (n = 241)
Median age, years (IQR) 46 (39–53)
Female gender, n (%) 206 (85.5)
Number of hemangiomas, n (%)
Solitary 167 (69.3)
Multiple 74 (30.7)
Intrahepatic distribution, n (%)
Superficial/subcapsular 128 (53.1)
Deeply situated 113 (46.9)
Hemangioma location
Left lobe 81 (33.6)
Right lobe 109 (45.2)
Bilateral 51 (21.2)
Median hemangioma size, cm (IQR) 8.5 (6–12.1)
Hemangioma hepatic involvement, n (%)
<25% 95 (39.4)
25–49% 105 (43.6)
50–74%+ 36 (14.9)
≥75% 5 (2.1)
History of cancer, n (%) 15 (6.2)
Hormonal therapy, n (%) 22 (9.1)
Concomitant liver cirrhosis 1 (0.3)
Albumin (mg/dl), mean (± SD) 4.0 (± 0.54)
Total bilirubin (mg/dl), mean (± SD) 0.68 (± 0.48)
INR, mean (± SD) 1.0 (± 0.11)
Clinical presentation, n (%)
Abdominal pain/discomfort 215 (89.2)
Incidental finding 41 (17)
Nausea/vomiting 32 (13.3)
Fatigue 10 (4.2)
Kasabach–Merritt Syndrome 1 (0.3)
Traumatic rupture/haemorrhage 3 (1.2)
Primary diagnostic study, n (%)
CT 154 (63.9)
MRI 51 (21.2)
Ultrasound 24 (10)
CT Angio/Angio 2 (0.8)
Other 10 (4.1)
IQR, interquartile range; INR, international normalized ratio; CT, com-
puted tomography; MRI, magnetic resonance imaging.
Table 2 Indications and operative details of patients that underwent
a hemangioma resection
Variable Patients (n = 241)
Indication for surgery, n (%)
Abdominal symptoms 204 (85)
Patient preference 9 (3.7)
Increase in size 28 (11.3)
Non-surgical therapy, n (%)
None 234 (97.1)
Embolization 7 (2.9)
Surgical therapy, n (%)
Resection/enucleation 229 (95)
Resection + ablation 12 (5)
Surgical approach, n (%)
Open 195 (80.9)
Laparoscopic 43 (17.8)
Robotic 3 (1.3)
Extent of resection, n (%)
Non-anatomic wedge resection 35 (14.5)
Segmentectomy 32 (13.3)
Bisegmentectomy 70 (29.1)
Right hepatectomy 73 (30.3)
Left hepatectomy 19 (7.9)
Extended right hepatectomy 6 (2.5)
Extended left hepatectomy 3 (1.2)
Central hepatectomy 3 (1.2)
Estimated blood loss (ml), median (IQR) 300 (150–650)
Blood transfusion, n (%)
None 215 (89.1)
1–3 units 19 (7.9)
≥4 units 7 (3)
IQR, interquartile range.
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were minor and only 2% of patients experienced potentially life-
threatening complications. Similarly, in a second study by
Erdogan, evolution of hemangioma-associated symptoms/
complications was not experienced among patients treated non-
operatively, thereby highlighting observation as a safe approach to
hemangioma management.12
In spite of the lack of a non-operative group in the present
series, the development of life-threatening events was an
extremely rare event with only three patients (1.2%) experiencing
a traumatic hemangioma rupture, necessitating surgical manage-
ment. One of the three patients suffered major abdominal trauma
after a motor vehicle collision, resulting in hemangioma rupture.
The second patient required emergent surgery after inadvertent
injury to the hemangioma during a routine laparoscopic cholecys-
tectomy. The third patient was identified as a spontaneous rupture
initially managed by embolization, but ultimately required formal
resection. Moreover, logistic regression failed to identify factors
associated with symptom development. Hemangiomas >5 cm, or
what has been described as giant hemangiomas in prior studies,
and hepatic distribution did not influence abdominal symptom
evolution.12 Therefore, proposing prophylactic resection in
asymptomatic patients solely as a result of hemangioma size or
enlargement is not adequate as the complications associated with
observation alone is typically mild and does not supersede the
associated surgical risk.
Lastly, a subgroup of patients commonly faced by clinicians are
the individuals who develop anxiety. While most studies, includ-
ing the present study would question anxiety as the sole surgical
indication, a recent series by Yedibela et al. reported performing
elective hepatectomies on 21 patients (20% of surgical cohort)
with asymptomatic lesions, who were otherwise limited by unre-
lenting anxiety.8 The authors concluded that surgical resection
was the only durable treatment option for this subset of patients.
In contrast, only a small percentage of patients in the present
study, which captures the practice pattern of multiple institutions,
used anxiety as an indication for operative management. With
effective non-operative measures currently available, and the low
risk of potentially life-threatening complications with observation
alone, it is difficult to accept the potential complications associ-
ated with surgery for an otherwise benign lesion.
There are several limitations of this retrospective review.Assess-
ment of symptom resolution and outcomes after surgery were
solely dependent on abstraction of medical records. Unlike the
study conducted by Schnelldorfer et al. which evaluated outcomes
through patient surveys, this study relied on information captured
in clinical encounters.7 The retrospective study design had the
potential for ascertainment and recording bias, which minimizes
the ability to objectively assess patient satisfaction and quality of
life after surgery.11 Without using established quality-of-life
assessment tools, interpreting symptom resolution in the present
study is subject to cautious interpretation.Additionally, a subset of
patients underwent surgery secondary to hemangioma enlarge-
ment. There is currently no established definition that addresses
the minimum growth required over a specified time interval,
which would warrant resection. Lastly, while studies have sug-
gested diagnostic uncertainty as an indication for hemangioma
resection, the present study was unable to capture this variable as
the true number of patients who underwent a resection secondary
to equivocal imaging results was unknown. However, improve-
Table 3 Peri-operative outcomes after a hepatic hemangioma
resection
Variable All patients
(n = 241)
Clavien grade ≥ III complication, n (%) 14 (5.7)
Types of complication
Bile leak 8 (3.4)
Bleeding 5 (2.2)
Liver failure 0
Length of hospitalization (days), median (IQR) 5 (4–6)
30 days readmission 13 (5.4)
Mortality, n (%)
Within 30 days of surgery 2 (0.8)
Within 90 days of surgery 0
Symptom resolution, n (%)*
Unchanged 15 (7.3)
Improved 129 (63.2)
Worse 6 (2.9)
Unknown 54 (26.6)
*Patients that underwent a resection owing to abdominal symptoms
(n = 204).
IQR, interquartile range.
Table 4 Univariate logistic regression: development of symptoms
Variable Univariate P
OR 95% CI
Age 0.98 0.95–1.00 0.131
Female gender 2.2 0.93–5.18 0.07
Number of hemangiomas
Solitary Ref – –
Multiple 0.59 0.29–1.23 0.16
Intrahepatic distribution
Deep Ref – –
Superficial 0.64 0.31–1.32 0.23
Hemangioma distribution
Left lobe Ref – –
Right lobe 1.68 0.75–3.76 0.21
Bilobar 1.06 0.43–2.64 0.90
Hemangioma size
≤5 cm Ref – –
>5 cm, ≤10 cm 1.05 0.40–2.76 0.91
>10 cm 0.91 0.34–2.44 0.85
OR, odds ratio; CI, confidence interval.
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ments in imaging techniques has resulted in diagnostic accuracy
rates as high as 95% with magnetic resonance imaging, thereby
contesting diagnostic uncertainty as a common indication.13
In conclusion, this study represents a large series of surgically
managed hemangiomas. Current practice patterns would suggest
that the majority of hemangiomas are being resected owing to
intractable abdominal symptoms, with overall good results.
Although hepatic resections are now able to be performed with
relatively low peri-operative morbidity, the low rates of life-
threatening events associated with non-operative management of
hemangiomas challenges the validity of additional surgical indi-
cations. Symptom severity must continue to be heavily scrutinized
prior to offering a surgical resection in order to justify the opera-
tive risk of liver surgery.
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